| Clinical data | |
|---|---|
| Trade names | Intracef, Velocef |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a601206 |
| Routes of administration | Oral,IM,IV |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Well absorbed |
| Protein binding | <10% |
| Metabolism | Nil |
| Eliminationhalf-life | 0.9 hours |
| Excretion | Renal, unchanged |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.049.199 |
| Chemical and physical data | |
| Formula | C16H19N3O4S |
| Molar mass | 349.41 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 140 to 142 °C (284 to 288 °F) (dec.) |
| |
| |
| (verify) | |
Cefradine (INN) orcephradine (BAN) is a first generationcephalosporinantibiotic.[1]
Cefradine is distributed in the form of capsules containing 250 mg or 500 mg, as a syrup containing 250 mg/5 ml, or in vials for injection containing 500 mg or 1 g.[citation needed]
It is not approved by the FDA for use in the United States.[citation needed]
Birch reduction of D-α-phenylglycine led to diene (2). This was N-protected usingtert-butoxycarbonylazide and activated for amide formation via the mixed anhydride method using isobutylchloroformate to give3. Mixed anhydride3 reacted readily with 7-aminodesacetoxycephalosporanic acid to give, after deblocking, cephradine (5).

The antibiotic is produced under many brand names across the world.[5]